Skip to main content
MDPI AG

Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives.

Publication ,  Preprint
Gathers, D; Oswalt, C; Alder, L; Chen, K; Higgins, J; Clarke, J; Oduah, E
May 5, 2025

Duke Scholars

DOI

Publication Date

May 5, 2025
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gathers, D., Oswalt, C., Alder, L., Chen, K., Higgins, J., Clarke, J., & Oduah, E. (2025). Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives. MDPI AG. https://doi.org/10.20944/preprints202505.0178.v1
Gathers, Diamone, Cameron Oswalt, Laura Alder, Kevin Chen, Jordyn Higgins, Jeffrey Clarke, and Eziafa Oduah. “Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives.MDPI AG, May 5, 2025. https://doi.org/10.20944/preprints202505.0178.v1.

DOI

Publication Date

May 5, 2025